Pricing
Login
Research AI
Products
Watchlists
Pricing
Login
Home
Charts
Search
Watchlist
Products
Symbiotec Pharmalab Ltd
SYMBIOTEC
₹
1,598.60
-0.39%
Symbiotec Pharmalab Ltd
SYMBIOTEC
NSE
BSE
₹
1,598.60
-0.39%
20 Nov 2026
Reports
Ask AI
Pharma API
Symbiotec Pharmalab Ltd
SYMBIOTEC
NSE
BSE
₹
1,598.60
-0.39%
20 Nov 2026
SOIC
x
StockScans Reports
Ask AI
Pharma API
2 indices
Growth Catalysts: The forward growth drivers and triggers.
Guidance Report: Management guidance vs outcomes.
Deep Dive Report: In-depth business analysis.
Financials
Documents
Shareholdings
Corporate Actions
Segments
Reports
Interviews
Announcements
Financials
Documents
Shareholdings
Corporate Actions
Segments
Reports
Interviews
Announcements
Annual Reports
No recent documents found for this company.
Quarterly Reports
FY2026
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Annual Reports
No recent documents found for this company.
Quarterly Reports
Submit a missing document
Sep 26
Result
PPT
Transcript
Summary
Jun 26
Result
PPT
Transcript
Summary
Load More
Interviews
7:13
FY27 Guidance | Q3 & Q4 Are Likely To Look Much Better For Us: Symbiotec Pharmalab | CNBC TV18
CNBC-TV18
·
2 months ago
9:16
Muted Listing | CDMO Business To Start Contributing To Revenues From This Year: Symbiotec Pharmalab
CNBC-TV18
·
3 months ago
18:18
Symbiotec Pharmalab IPO | Top Management On Growth Plans, Business Outlook & IPO Strategy
Business Today
·
3 months ago
17:53
5 IPOs Set To Hit The Market: Where Are The Opportunities?
NDTV Profit
·
3 months ago
·
+1 company
5:46
Symbiotec Pharmalab IPO | Chairman & MD Anil Satwani और CFO Raghavender Ramachandran से खास बातचीत
CNBC Awaaz
·
3 months ago
11:05
Symbiotec Pharmalab's ₹1,757 Cr IPO Opens | Expect To Reduce Debt To ₹280 Cr Post IPO, Says Company
CNBC-TV18
·
3 months ago
Load More
Announcements
Announcements